Study Links PFAS Exposure To Faster Biological Aging

Two lesser-known forever chemicals may be quietly accelerating biological aging in older Americans, according to new research published in Frontiers in Aging.

The study, titled Emerging PFAS contaminants PFNA and PFSA amplify epigenetic aging: sex- and age-stratified risks in an aging population, analyzed data from 326 U.S. adults aged 50 and above and found that exposure to PFNA and PFSA, two members of the per- and polyfluoroalkyl substances (PFAS) family, was associated with measurable acceleration in biological aging markers.

PFAS are synthetic chemicals widely used in industrial applications and consumer products for their resistance to heat, oil and water. Often referred to as forever chemicals because they persist in the environment and the human body, PFAS contamination has been detected in drinking water supplies affecting millions of Americans. While earlier research has linked PFAS to cancer, immune dysfunction, reproductive disorders and cardiovascular risks, the new study explores a deeper question: whether these chemicals may also speed up the aging process itself.

Using data from the 1999–2000 cycle of the National Health and Nutrition Examination Survey (NHANES), researchers examined serum levels of several PFAS compounds alongside 12 DNA methylation–based epigenetic clocks. These clocks estimate biological age by measuring chemical modifications to DNA that reflect cumulative physiological stress.

The strongest signals emerged for PFNA. Higher PFNA levels were significantly associated with accelerated aging in mortality-related epigenetic markers, particularly GrimAgeMort and GrimAge2Mort, two clocks known to predict lifespan and health risk. The associations were notably stronger in men and in adults aged 50 to 64, suggesting potential sex- and age-specific vulnerability.

PFSA, another emerging PFAS compound, showed links to LinAge, a lifespan-related aging metric, though associations were more limited compared to PFNA.

Importantly, traditional high-profile PFAS such as PFOA and PFOS did not show consistent associations with epigenetic aging in this analysis. The findings point toward growing concern over newer or less-studied PFAS variants that may carry distinct biological risks.

The researchers caution that the study is cross-sectional, meaning it cannot establish cause and effect. Some associations weakened after statistical correction for multiple testing, and the relatively small sample size limits definitive conclusions. Nevertheless, the findings remained robust even after adjusting for lifestyle, socioeconomic and inflammatory factors.

From a public health perspective, the study underscores the need to consider sex- and age-specific risk patterns when evaluating PFAS exposure. It also highlights the emerging role of epigenetic biomarkers such as GrimAge and LinAge, in detecting early, subclinical impacts of environmental contaminants long before overt disease develops.

As regulators worldwide intensify scrutiny of PFAS contamination, the research adds another layer to the debate: exposure may not only raise disease risk but could also influence how quickly the body biologically ages.

The authors call for larger, longitudinal studies to confirm the findings and clarify the causal pathways. But the message is clear, the health consequences of PFAS exposure may extend beyond immediate toxic effects, potentially altering the biological clock itself.